Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Frontiers in Bioengineering and Biotechnology is Scopus-indexed (Q1, CiteScore 10.6), WoS SCIE, DOAJ. Published by Frontiers Media SA.
Checked against the index lists dated .
ISSN 2296-4185Verify ISSN ↗
Publisher: Frontiers Media SA
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Histology | 4 / 62 | 94th | Q1 |
| Biotechnology | 50 / 325 | 84th | Q1 |
| Biomedical Engineering | 56 / 342 | 83rd | Q1 |
| Bioengineering | 29 / 168 | 83rd | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2013–present, best quartile Q1, CiteScore 10.6.
Frontiers in Bioengineering and Biotechnology is Q1 in Histology (rank 4 of 62), Q1 in Biotechnology (rank 50 of 325) and Q1 in Biomedical Engineering (rank 56 of 342), by CiteScore 2025. It is ranked in 4 subject areas in all.
Frontiers in Bioengineering and Biotechnology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 10.6, which places it in quartile Q1 at the 94th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.024, quartile Q1, with an H-index of 144.
The publisher lists an article processing charge of about US$3,801 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Frontiers in Bioengineering and Biotechnology is published by Frontiers Media SA. Its ISSN is 2296-4185.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Frontiers in Bioengineering and Biotechnology has an h-index of 175 and a 2-year mean of 6.19 citations per paper (OpenAlex). Its Scopus CiteScore is 10.6, quartile Q1. On 2-year citations it ranks #4 of 61 Scopus journals in Histology.
Frontiers in Bioengineering and Biotechnology published 1,221 papers in 2025; its busiest recent year was 2022 with 2,566. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2026), authors are most often from China (52.9%), United States (8%) and Germany (4.3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 30 retracted papers are recorded (2 per 1,000 papers). The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.